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Abstract
Objectives: To evaluate bone loss around implants placed in patients with a history of treated chronic periodontitis 
and who did or did not attend supportive periodontal therapy, after one year in function. Furthermore, the influ-
ence of periodontal biotype and level of plaque was also evaluated.
Material and Methods: Forty-nine patients participated voluntarily in the study. All subjects had a history of 
chronic periodontitis, which had been previously treated. After the active treatment, 27 patients attended support-
ive periodontal therapy (SPT) and the rest did not (No SPT).
The O’Leary plaque index and periodontal biotype were recorded for each subject and 246 Astra Tech® Osseo-
speedTM implants were radiographically analysed (123 placed in SPT patients and 123 in No SPT patients) at the 
time of loading and one year later, measuring marginal bone loss with the program Dental Studio NX 6.0®. The 
statistical analysis was performed with Windows SPSS, applying Pearson’s correlation index and the Kruskal-
Wallis and U-Mann Whitney non-parametric tests.
Results: Six patients were found to have periimplantitis and sixteen mucositis. The survival rate was 99.59% 
(100% SPT and 99.18% No SPT). Mean bone loss was 0.39 mm (range [-0.71 - 8.05]). Among SPT patients, 95% of 
the implants had losses less than or equal to the mean (mean bone loss of 0.16 mm) compared to 53.7% for the No 
SPT group (mean bone loss of 0.62 mm). A statistically significant relationship was demonstrated between bone 
loss around the implant and the patient’s periodontal biotype and plaque index.
Conclusions: The marginal bone loss around implants in patients with treated chronic periodontitis is minimal if 
they are in a controlled SPT programme and there is individual control of plaque index. Moreover, the presence of 
a thin periodontal biotype represents a risk factor for additional bone loss.
Key words: Peri-implantitis, chronic periodontitis, bacterial plaque, periodontal biotype.
Med Oral Patol Oral Cir Bucal. 2013 Sep 1;18 (5):e786-92.                                                                                                                                                         Implants in patients with periodontitis
e787
Introduction
Dental implants have become predictable in the treat-
ment of totally or partially edentulous patients (1,2). 
The survival of implants is high, but not free of com-
plications, being one of the most frequent periimplant 
inflammation (3). We refer to two conditions when dis-
cussing this disease: periimplant mucositis and periim-
plantitis. Mucositis is defined as an inflammatory lesion 
of infectious origin residing in the periimplant mucosa; 
when this involves the loss of supporting bone it would 
be referred to as periimplantitis. The presence of red-
dening, inflammation and bleeding on probing would 
assist in the diagnosis of the first entity and, if an in-
crease in probing depth and suppuration together with 
marginal supporting bone loss, confirmed by X-ray, is 
also present, it would indicate periimplantitis (4,5).
 The infectious ethiology of periimplantitis has been 
confirmed in several papers (3,6-9). Similarly, bone loss 
has been linked to the presence of risk factors such as 
systemic diseases (10), the type of implant surface (11) 
and smoking (12) among others.
The periodontal biotype concept was established by 
Seibert and Lindhe in 1989 (13). Claffey and Shanley 
(14) proposed a thickness lower than 1.5 millimetres for 
the mucosa for thin biotypes and greater than or equal 
to 2 millimetres for thick biotypes, and suggested that 
the former are more susceptible to plaque accumulation 
and pathologies (inflammation, bleeding and recession). 
Furthermore, the importance of having good keratinised 
mucosa around implants in order to achieve predictable 
aesthetic results is well known (15,16). 
The objective of this study was to evaluate bone loss 
around Astra Tech® implants placed in patients with a 
history of treated chronic periodontitis who did or did 
not attend supportive periodontal therapy, after one year 
in function, and the influence that periodontal biotype 
and level of plaque may have.
Material and Methods
Forty-nine subjects, 18 men and 31 women, with a mean 
age of 47.6 years [38-66], who had been treated in the 
Postgraduate Periodontics Department of Universidad 
del País Vasco/Euskal Herriko Unibertsitatea for chronic 
periodontitis and who subsequently received oral rehabili-
tation with implant-supported prosthesis, were scheduled 
for reevaluation after having the prosthesis in function 
for one year. Despite being informed of the importance 
of receiving supportive periodontal therapy (SPT), 27 at-
tended the appointments (SPT) and 22 did not (No SPT). 
None of these patients were suffering from systemic dis-
eases, five presented craneo-mandibular dysfunction and 
only three were occasional smokers. 
All data were collected after the first year in function 
and the patients participated voluntarily in the study, 
after being properly informed. 
A 4-monthly visit protocol was established, which includ-
ed: a) evaluation of plaque index (17), b) determination of 
probing depth and gingival index (18) by means of a peri-
odontal probe (Williams Hu-Friedy, Chicago, IL, USA); 
c) professional prophylaxis in implants (titanium curettes, 
carbon-fibre curettes, rubber cup and prophylaxis paste), 
and teeth (piezoelectric ultrasound with a frequency of 30 
KHz [H3, Suprasson®, Satelec, Bordeaux, France] and 
Gracey Curettes [Hu-Friedy, Chicago, IL, USA]), d) oc-
clusal analysis with 12 micron articulating paper (Bausch 
Arti-Fol® Metallic BK28; KG, Cologne, Germany), e) X-
rays (orthopantomography or intraoral X-rays performed 
using the parallel technique) every 6 months and f) rein-
forcement of personal motivation to control plaque. 
A total of 246 Astra Tech® Osseospeed™ implants were 
analysed (Astra Tech AB, Mölndal, Sweden), along 
with their prostheses: 84 fixed metal-ceramic prosthe-
ses (single-unit and bridges), 14 fixed metal-resin hybrid 
prostheses and one over-denture. All of these prostheses 
substituted teeth that were lost as a result of the peri-
odontal disease suffered.
Periodontal biotype was evaluated according to the ana-
tomical characteristics of each patient and according to 
two standards: thin biotype or thick biotype (19). 
Bone loss was measured from the implant abutment to 
the most coronal bone-to-implant contact point, both 
Fig. 1. a) X-ray containing the references used 
in the measurements made from the implant 
shoulder to bone level, both mesially and dis-
tally. b) X-ray at the time of implant loading, 
showing that the bone margin coincides with 
the implant shoulder. c) X-ray after one year of 
functional loading in a patient who has received 
supportive periodontal therapy. The mainte-
nance of the bone level can be observed. 
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mesially and distally (Fig. 1) with the programme Den-
tal Studio NX version 6.0® (NEMOTEC) over pre-
scanned orthopantomography and intraoral X-rays at 
the time of loading (Fig. 1) and one year after (Fig. 1). 
The statistical analysis of the data was performed with 
the Windows software SPSS version 14.0 and was based 
on the analysis of mean bone loss. Descriptive analy-
ses of means, correlations and non-parametric contrasts 
were performed with the aim of finding significant dif-
ferences between the groups defined by periodontal 
biotype and those who received or did not receive sup-
portive periodontal therapy.
The failure of the data to confirm the normality hy-
pothesis meant that ANOVA or t-tests could not be per-
formed; the non-parametric tests, U-Mann Whitney to 
contrast two samples, and Kruskal-Wallis to contrast 
more than two samples were therefore performed. As 
the plaque index is a continuous quantitative variable, 
Pearson’s Correlations were performed.
Results
One implant was lost during this year (Figs. 2,3), ren-
dering a total survival rate of 99.59% (100% for SPT 
and 99.18% for No SPT). Six patients (12%) presented 
typical signs of periimplantitis in at least one fixture, 
five in the No SPT group (22.7%) and one in the SPT 
group (3.7%). Furthermore, it was observed that sixteen 
patients (32%) presented an implant with signs of mu-
cositis, eleven in the No SPT group (50%) and five in the 
SPT group (18.5%).
Fig. 2. Failed implant in a patient who did not re-
ceive supportive periodontal therapy.
Fig. 3. Prosthesis in which a large quantity 
of retained calculus can be observed in a 
patient who did not receive maintenance 
therapy.
 PLAQUE
MESIAL 
LOSS 
Pearson’s correlation 0.31
Sig. (bilateral) 6.07E-07
N 246
DISTAL 
LOSS 
Pearson’s correlation 0.37
Sig. (bilateral) 2.43E-09
N 246
MEAN LOSS 
Pearson’s correlation 0.35
Sig. (bilateral) 1.59E-08
N 246
Table 1. Correlations between bacterial plaque and bone loss 
(Numerical value from 0 to 1).
The mean plaque index was 39.98% [17-90]. The mean 
plaque index was 20.34% [17-24] in the SPT group 
and 59.63% [38-90] in the No SPT group, with a sta-
tistically significant correlation with respect to bone 
loss around their fixtures during the first year (p= 
1.59×10–8). (Table 1).
Mean bone loss was 0.39 mm (SD 0.71; range [(-0.71)-
8.05]), with distal loss (0.45 mm; SD 0.75) being greater 
than mesial loss (0.33 mm; SD 0.70). In patients who 
received SPT, mean bone loss was 0.16 mm (SD 0.15; 
[0-1.24]), while in the No SPT group a loss of 0.62 mm 
(SD 0.94; range [(-0.71)-8.05]) was observed. This dif-
ference was statistically significant (p= 5.15×10–13) (Ta-
ble 2). Furthermore, in the SPT group, 95.9% of the im-
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Table 2. Attachment loss level at 12 months in SPT and No SPT implants (in millimetres).
                     MESIAL 
LOSS 
DISTAL 
LOSS 
MEAN 
LOSS 
NO SPT            
N 123 123 123
Mean 0.52 0.72 0.62
Std. Dev. 0.94 0.99 0.94
Minimum –0.71 –0.02 –0.28
Maximum 8.00 8.05 8.03
SPT                   
N 123 123 123
Mean 0.13 0.19 0.16
Std. Dev. 0.15 0.17 0.15
Minimum 0.00 0.00 0.00
Maximum 1.01 1.24 1.13
Total                  
N 246 246 246
Mean 0.33 0.45 0.39
Std. Dev. 0.70 0.76 0.71
Minimum –0.71 –0.02 –0.28
Maximum 8.00 8.05 8.03
Mann-Whitney U test 4014.50 3761.00 3537.00
Asymptotic sig. (bilateral) 1.76E-10 8.93E-12 5.15E-13
plants (118) experienced less bone loss than the mean 
versus 53.7% (66) of the implants in the No SPT group. 
To assess the influence of periodontal biotype, the 
Kruskal-Wallis test was applied and significant diffe-
rences were observed in bone loss (p= 1.31×10–16) in the 
different groups, although the most evident results were 
observed when comparing the fixtures placed in patients 
with a thick biotype in the SPT group (64 implants in 16 
subjects), with a mean bone loss of 0.09 mm (SD 0.08; 
[0-0.45]), to the implants placed in patients with a thin 
biotype in the No SPT group (73 fixtures placed in 11 
patients), with a mean bone loss of 0.78 mm (SD 1.14; 
[(-0.23)-8.05]) (Table 3).
Five of the six cases of periimplantitis mentioned above 
were related to thin biotypes and one to thick biotype. 
Similarly, of the sixteen cases of mucositis, twelve were 
related to thin biotypes and four to thick biotypes. 
With respect to the bleeding index and probing depth, 
given the design of some of the prostheses and the dif-
ficulty in correctly evaluating these parameters in each 
and every patient and implant, a correct statistical 
analysis could not be performed. A 24.2% of the pros-
theses could not be probed due to their design, being 
these prostheses related with four of the patients with 
periimplantitis (66.6%) and thirteen of the patients with 
mucositis (81.2%). 
Discussion
The studies published on the Astra Tech® implant sys-
tem in professionally monitored patients with good hy-
giene report mean bone losses during the first year in 
function between 0.02 and 0.4 mm (20,21).
Cecchinato et al. (22) studied the bone changes around 
Astra Tech® implants analysing 115 fixed partial pros-
theses supported by 324 fixtures in 84 patients. The 
implant placement protocol used procedures in one and 
two stages (groups A and B) and mean bone losses dur-
ing the first year of functional loading of 0.02 and 0.17 
mm were observed for the respective groups. The re-
sults obtained by Wennstrom et al. (23) with regard to 
the single fixed prosthesis were similar. A total of 45 
fixtures were analysed, with a mean bone loss of 0.02 
mm during the first year in function.
For other implant systems and the “periodontally sta-
ble” patient type, normal bone loss is considered to be 
between 0.1 and 1.6 mm during the first years of func-
tional loading (24,25). 
Studies published on the long-term evolution of im-
plants placed in patients who have previously been 
treated for chronic periodontitis do not contraindicate 
their installation, although studies suggest a lower sur-
vival rate and greater number of biological complica-
tions (26,27).
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The number of fixtures with complications in periodon-
tal patients after loading is in the range of 0-21% (26-
29). However, when these patients are included in an 
SPT programme this range is greatly reduced [0-3.9%] 
(28,29).
Wennström et al. (30) observed a mean bone reduction 
of 0.33 mm during the first year in function in 149 As-
tra Tech® implants placed in 51 patients who had been 
treated for chronic periodontitis and included in a main-
tenance protocol. 
It is worth mentioning the study by Mengel and Flores-
de-Jacoby (29), in which the authors compared the re-
sults of 150 implants (Brånemark System Implants® 
and 3i Implant Innovations®) placed in three patient 
   MESIAL 
LOSS
DISTAL 
LOSS
MEAN
LOSS
NO SPT 
THIN BIOTYPE 
N 73 73 73 
Mean 0.67 0.90 0.78 
Std. Dev. 1.15 1.19 1.14 
Minimum –0.23 –0.02 –0.03 
Maximum 8.00 8.05 8.03 
THICK BIOTYPE   N 50 50 50 
Mean 0.30 0.47 0.38 
Std. Dev. 0.39 0.47 0.40 
Minimum –0.71 0.06 –0.28 
Maximum 1.96 2.52 2.24 
TOTAL N 123 123 123 
Mean 0.52 0.72 0.62 
Std. Dev. 0.94 0.99 0.94 
Minimum –0.71 –0.02 –0.28 
Maximum 8.00 8.05 8.03 
SPT 
THIN BIOTYPE 
N 59 59 59 
Mean 0.20 0.27 0.23 
Std. Dev. 0.17 0.20 0.17 
Minimum 0.00 0.00 0.00 
Maximum 1.01 1.24 1.13 
THICK BIOTYPE N 64 64 64 
Mean 0.08 0.11 0.09 
Std. Dev. 0.09 0.08 0.08 
Minimum 0.00 0.00 0.00 
Maximum 0.45 0.25 0.35 
TOTAL N 123 123 123 
Mean 0.13 0.19 0.16 
Std. Dev. 0.15 0.17 0.15 
Minimum 0.00 0.00 0.00 
Maximum 1.01 1.24 1.13 
TOTAL
THIN BIOTYPE 
N 132 132 132 
Mean 0.46 0.61 0.54 
Std. Dev. 0.89 0.95 0.90 
Minimum –0.23 –0.02 –0.03 
Maximum 8.00 8.05 8.03 
THICK BIOTYPE N 114 114 114 
Mean 0.17 0.27 0.22 
Std. Dev. 0.29 0.36 0.31 
Minimum –0.71 0.00 –0.28 
Maximum 1.96 2.52 2.24 
TOTAL N 246 246 246 
Mean 0.33 0.45 0.39 
Std. Dev. 0.70 0.76 0.71 
Minimum –0.71 –0.02 –0.28 
Maximum 8.00 8.05 8.03 
Chi-squared 61.18 71.02 77.05 
Asymptotic sig. 3.29E-13 2.58E-15 1.31E-16 
Table 3. Attachment loss level at 12 months in SPT and No SPT implants and according to periodontal biotype (in 
millimetres).
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groups: periodontally healthy patients, patients pre-
viously treated for chronic periodontitis and patients 
treated for generalised aggressive periodontitis. Loss of 
bone level after one year was 0.58 mm, 0.68 mm and 
0.83 mm respectively, increasing at three years to 0.12 
mm, 0.18 mm and 0.31 mm for the different groups. 
This study would suggest that not only is periodontitis a 
risk factor for attachment loss, but also that the type of 
periodontitis can have an effect. 
In the present study, the survival rate during the first 
year in function was 99.59% (100% SPT and 99.18% No 
SPT) and mean bone loss was 0.39 mm, being 0.16 mm 
in SPT patients and 0.62 mm in the No SPT group. The 
difference observed between the patients who received 
SPT and those who did not, can be explained by the cor-
relation observed between plaque index and bone loss 
(0.35) (Table 1). This value does not establish a causal 
relationship, but does indicate that there is a greater ten-
dency to bone loss when plaque index is high or that, in 
the absence of a high plaque index, minor losses will 
more likely occur. 
In this regard, Quirynen et al. (31) emphasize the im-
portance of supportive periodontal therapy in patients 
with a history of periodontitis and treated with rough 
surface fixtures. 
In this paper, five of the six patients with periimplanti-
tis were subjects who did not attend maintenance and 
66.6% of these, together with 81.2% of the patients who 
presented implants with some sign of mucositis, had 
prostheses that could not be correctly probed, as dem-
onstrated by Serino and Ström (32). 
Periodontal biotype also seems to play a role in patients 
with implants (15,16). In this study, great differences 
have been observed between the No SPT patients with 
thin biotypes, with a mean bone loss of 0.78 mm, and 
the SPT patients with a thick biotype, in which a mean 
bone loss of 0.09 mm was observed. These differences 
would not only be explained by a good plaque control, 
but also would indicate that the level of bone around a 
fixture at the moment of its installation is a significant 
prognostic factor with regard to its evolution over time. 
Conclusion
Within the limitations of this study, e.g. the sample size 
and the study duration, the results demonstrate the good 
behaviour of the Astra Tech® implant system during the 
first year of functional loading in patients with treated 
periodontal pathology. 
Furthermore, it indicates that establishing a regulated 
maintenance protocol after the active phase of peri-
odontal treatment is essential in order to minimize the 
risk of marginal bone loss in implants placed in peri-
odontal patients. 
It also illustrates the influence that two factors, plaque 
index and periodontal biotype, have on bone loss after 
loading the implants, especially when implants placed 
in thin biotypes without maintenance are compared to 
fixtures placed in thick biotypes with maintenance. 
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